BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27836986)

  • 1. Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury.
    Carnemolla R; Villa CH; Greineder CF; Zaitsev S; Patel KR; Kowalska MA; Atochin DN; Cines DB; Siegel DL; Esmon CT; Muzykantov VR
    FASEB J; 2017 Feb; 31(2):761-770. PubMed ID: 27836986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis.
    Zaitsev S; Kowalska MA; Neyman M; Carnemolla R; Tliba S; Ding BS; Stonestrom A; Spitzer D; Atkinson JP; Poncz M; Cines DB; Esmon CT; Muzykantov VR
    Blood; 2012 May; 119(20):4779-85. PubMed ID: 22493296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anchoring fusion thrombomodulin to the endothelial lumen protects against injury-induced lung thrombosis and inflammation.
    Ding BS; Hong N; Christofidou-Solomidou M; Gottstein C; Albelda SM; Cines DB; Fisher AB; Muzykantov VR
    Am J Respir Crit Care Med; 2009 Aug; 180(3):247-56. PubMed ID: 19342415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet endothelial cell adhesion molecule targeted oxidant-resistant mutant thrombomodulin fusion protein with enhanced potency in vitro and in vivo.
    Carnemolla R; Greineder CF; Chacko AM; Patel KR; Ding BS; Zaitsev S; Esmon CT; Muzykantov VR
    J Pharmacol Exp Ther; 2013 Nov; 347(2):339-45. PubMed ID: 23965383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor.
    Greineder CF; Chacko AM; Zaytsev S; Zern BJ; Carnemolla R; Hood ED; Han J; Ding BS; Esmon CT; Muzykantov VR
    PLoS One; 2013; 8(11):e80110. PubMed ID: 24244621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
    Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
    Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatible coupling of therapeutic fusion proteins to human erythrocytes.
    Villa CH; Pan DC; Johnston IH; Greineder CF; Walsh LR; Hood ED; Cines DB; Poncz M; Siegel DL; Muzykantov VR
    Blood Adv; 2018 Feb; 2(3):165-176. PubMed ID: 29365311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lectin-like domain of thrombomodulin protects against ischaemia-reperfusion lung injury.
    Geudens N; Van de Wouwer M; Vanaudenaerde BM; Vos R; Van De Wauwer C; Verleden GM; Verbeken E; Lerut T; Van Raemdonck DE; Conway EM
    Eur Respir J; 2008 Oct; 32(4):862-70. PubMed ID: 18508817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombomodulin administration attenuates ischemia-reperfusion injury of the remnant liver after 70% hepatectomy in rats: simulated model of small-for-size graft in living donor liver transplantation.
    Tanemura A; Kuriyama N; Azumi Y; Ohsawa I; Kishiwada M; Mizuno S; Usui M; Sakurai H; Tabata M; Isaji S
    Transplant Proc; 2014 May; 46(4):1107-11. PubMed ID: 24815140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C protects against renal ischaemia/reperfusion injury, independent of its anticoagulant properties.
    Lattenist L; Jansen MP; Teske G; Claessen N; Meijers JC; Rezaie AR; Esmon CT; Florquin S; Roelofs JJ
    Thromb Haemost; 2016 Jul; 116(1):124-33. PubMed ID: 27052416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombomodulin as an intravascular safeguard against inflammatory and thrombotic diseases.
    Ito T; Kakihana Y; Maruyama I
    Expert Opin Ther Targets; 2016; 20(2):151-8. PubMed ID: 26558419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombomodulin improved liver injury, coagulopathy, and mortality in an experimental heatstroke model in mice.
    Kawasaki T; Okamoto K; Kawasaki C; Sata T
    Anesth Analg; 2014 May; 118(5):956-63. PubMed ID: 24781566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Differentiation of Thrombomodulin Alfa and Activated Protein C on Coagulation and Fibrinolysis In Vitro.
    Tanaka K; Tawara S; Tsuruta K; Hoppensteadt D; Fareed J
    Clin Appl Thromb Hemost; 2018 Sep; 24(6):859-866. PubMed ID: 29683037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats.
    Hasegawa N; Kandra TG; Husari AW; Veiss S; Hart WT; Hedgpeth J; Wydro R; Raffin TA
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1831-7. PubMed ID: 8665042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of human urinary thrombomodulin on ischemia- reperfusion injury in the canine liver.
    Kaneko H; Joubara N; Yoshino M; Yamazaki K; Mitumaru A; Miki Y; Satake H; Shiba T
    Eur Surg Res; 2000; 32(2):87-93. PubMed ID: 10810213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications.
    Okajima K
    Clin Chem Lab Med; 2004 Feb; 42(2):132-41. PubMed ID: 15061350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICAM-1-targeted thrombomodulin mitigates tissue factor-driven inflammatory thrombosis in a human endothelialized microfluidic model.
    Greineder CF; Johnston IH; Villa CH; Gollomp K; Esmon CT; Cines DB; Poncz M; Muzykantov VR
    Blood Adv; 2017 Aug; 1(18):1452-1465. PubMed ID: 29296786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microcirculatory alterations in ischemia-reperfusion injury and sepsis: effects of activated protein C and thrombin inhibition.
    Hoffmann JN; Vollmar B; Laschke MW; Fertmann JM; Jauch KW; Menger MD
    Crit Care; 2005; 9 Suppl 4(Suppl 4):S33-7. PubMed ID: 16168073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble thrombomodulin protects ischemic kidneys.
    Sharfuddin AA; Sandoval RM; Berg DT; McDougal GE; Campos SB; Phillips CL; Jones BE; Gupta A; Grinnell BW; Molitoris BA
    J Am Soc Nephrol; 2009 Mar; 20(3):524-34. PubMed ID: 19176699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombomodulin--a new target for treating stroke at the crossroad of coagulation and inflammation.
    Wenzel J; Assmann JC; Schwaninger M
    Curr Med Chem; 2014; 21(18):2025-34. PubMed ID: 24372210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.